Cartesian Therapeutics, Inc. ( RNAC) - Key Metrics
RNAC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | $0.47 | -$0.70 | -$0.71 |
| 2026Q1 | $0 | -$1.46 | -$0.82 | -$0.83 |
| 2025Q4 | $0.04 | -$3.56 | -$0.68 | -$0.70 |
| 2025Q3 | $0.02 | -$1.38 | -$0.60 | -$0.65 |
| 2025Q2 | $0.01 | $0.61 | -$0.67 | -$0.77 |
RNAC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 5.54 |
| 2026Q1 | 0% | -1.05 |
| 2025Q4 | 0% | -0.51 |
| 2025Q3 | 0% | -1.85 |
| 2025Q2 | 0% | 4.26 |
RNAC
Price: $10.37
52 week price:
Earnings Per Share: -5.72 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 265.0 million